Short answer: CJC-1295 with DAC has a half-life of about 8 days (Teichman SL, et al. 2006) and reaches steady state after about 40 days (~5.7 weeks) of regular dosing. We could not confirm a published time to peak for CJC-1295 with DAC, so we do not state one. With the same total per week, Dose Track's model gives a peak-to-trough swing of about 1.25:1 twice weekly and about 1.67:1 weekly.
Relative units: 1 on the scale is one full dose. There is no FDA label dose for this use, so the chart shows the shape of the curve, not an amount. Dashed line: 5 half-lives. Change the amount or schedule in the calculator.
We could not confirm a published time to peak for CJC-1295 with DAC, so we do not state one. The curve still needs a rise time, so it uses the app's modeling estimate; treat the shape of the first day or two as approximate.
With regular dosing at a fixed amount and interval, levels climb toward steady state by the same fraction every half-life, whatever the dose. At a half-life of about 8 days:
| Share of steady state | Half-lives | Time |
|---|---|---|
| 50% | 1 | 8 days |
| 75% | 2 | 16 days |
| 90% | 3.3 | 27 days (~3.8 weeks) |
| 97% (Dose Track's steady-state rule) | 5 | 40 days (~5.7 weeks) |
The longer the gap between doses compared with the half-life, the bigger the swing from peak to trough and the less the levels build up. These ratios do not depend on the amount.
| Interval | Peak : trough | Build-up vs one dose |
|---|---|---|
| Daily | 1.04 : 1 | 12.05× |
| Every other day | 1.11 : 1 | 6.29× |
| Twice weekly | 1.25 : 1 | 3.82× |
| Weekly | 1.67 : 1 | 2.2× |
| Every 2 weeks | 3.04 : 1 | 1.42× |
Build-up is the accumulation ratio 1 / (1 − e−k·τ), with k = ln 2 / half-life and τ the interval.
After the last dose, about half is gone every 8 days. After 5 half-lives, about 40 days (~5.7 weeks), roughly 97% has cleared in the model.
A study in healthy adults (Teichman 2006) estimated a half-life of 5.8 to 8.1 days. We could not confirm a time to peak, so we leave it out.
The curve uses the half-life, time to peak, route and bioavailability built into the Dose Track app for CJC-1295 with DAC, and the same one-compartment model with first-order absorption. These are modeled estimates from published half-lives, drawn with the same one-compartment model as the Dose Track app. Real levels vary from person to person, and only a lab test measures them. This is not medical advice and not a dosing recommendation; dosing decisions belong with you and your prescriber.
Vial sizes and syringe math are in the CJC-1295 with DAC guide.
Semaglutide · Tirzepatide · Retatrutide · Cagrilintide · Dulaglutide · Liraglutide · Testosterone Cypionate · Testosterone Propionate · hCG · Anastrozole · Exemestane · HGH · Tesamorelin · Ipamorelin · Thymosin Alpha-1
Half-life calculator · Compound guides · Reconstitution calculator